What happens to the bone structure after normocalcemic primary hyperparathyroidism surgery?

被引:8
|
作者
Osorio-Silla, Irene [1 ]
Gomez-Ramirez, Joaquin [2 ]
Valdazo-Gomez, Adela [3 ]
Salido Fernandez, Sergio [1 ]
Sanchez Garcia, Carmen [1 ]
Pardo Garcia, Ricardo [1 ]
机构
[1] Univ Hosp Fdn Jimenez Diaz, Dept Surg, Madrid, Spain
[2] Univ Hosp Ramon Y Cajal, Dept Surg, Madrid, Spain
[3] Univ Hosp Infanta Leonor, Dept Surg, Madrid, Spain
关键词
MINERAL DENSITY; TURNOVER MARKERS; PARATHYROIDECTOMY; OUTCOMES;
D O I
10.1016/j.surg.2021.08.047
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bone disease in primary hyperparathyroidism is a clear indication for surgical treatment. However, it is not known whether surgery benefits hypercalcemic primary hyperparathyroidism and normocalcemic primary hyperparathyroidism equally. The aim of our study was to evaluate the bone changes in patients undergoing parathyroidectomy based on the biochemical profile 1 and 2 years after surgery. Methods: This prospective study included 87 consecutive patients diagnosed with primary hyperparathyroidism who underwent surgery between 2016 and 2018. Bone densitometry (1/3 distal radius, lumbar, and femur) and bone remodeling markers (osteocalcin, type 1 procollagen [P1NP], beta-cross-linked telopeptide of type I collagen [BCTX]) were performed preoperatively and postoperatively. Postoperative changes in bone mineral density and bone markers were compared and evaluated according to the clinical characteristics and the individual biochemical profile. Results: One year after surgery, all patients showed an increase in bone mineral density at the lumbar site (mean, 0.029 g/cm(2); range, 0.017-0.04; P < .001) and femur neck (mean, 0.025 g/cm(2); range, 0.002-0.05; P < .001); however, there were no changes in the distal third of the radius (mean, -0.003 g/cm(2); range, -0.008 to 0.002; P = NS). There were no significant differences when comparing normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism. Serum osteocalcin (37 +/- 17.41), P1NP (67.53 +/- 31.81) and BCTX (0.64 +/- 0.37) levels were elevated before surgery. One year after the surgery, we observed a significant decrease in P1NP (33.05 +/- 13.16, P = .001), osteocalcin (15.80 +/- 6.19, P = .001), and BCTX (0.26 +/- 0.32, P < .001) levels. . Conclusion: Our findings indicate that parathyroidectomy has similar benefits for normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism in terms of bone improvement. Although the most substantial improvement occurred during the first postoperative year in both groups, we consider that studies with longer follow-up are warranted. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:932 / 939
页数:8
相关论文
共 50 条
  • [1] BONE METABOLISM IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM
    Yankova, I.
    Shinkov, A.
    Kovatcheva, R.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S319 - S319
  • [2] Normocalcemic primary hyperparathyroidism
    Bilezikian, John P.
    Silverberg, Shonni J.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (02) : 106 - 109
  • [3] Normocalcemic primary hyperparathyroidism
    Cusano, Natalie E.
    Cetani, Filomena
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (05): : 666 - 677
  • [4] NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM
    WILLS, MR
    PAK, CYC
    HAMMOND, WG
    BARTTER, FC
    AMERICAN JOURNAL OF MEDICINE, 1969, 47 (03): : 384 - +
  • [5] Normocalcemic Primary Hyperparathyroidism
    Cusano, Natalie E.
    Silverberg, Shonni J.
    Bilezikian, John P.
    JOURNAL OF CLINICAL DENSITOMETRY, 2013, 16 (01) : 33 - 39
  • [6] NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM
    GRIMELIU.L
    JOHANSSO.H
    LINDQUIS.B
    THOREN, L
    WERNER, I
    ACTA CHIRURGICA SCANDINAVICA, 1973, 139 (01): : 42 - 44
  • [7] Surgery for Normocalcemic Hyperparathyroidism
    Kulkarni, Pallavi
    Goldenberg, David
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2024, 57 (01) : 111 - 116
  • [8] Normocalcemic primary hyperparathyroidism
    Spivacow, Francisco R.
    Sapag Duran, Ana
    Zanchetta, Maria B.
    MEDICINA-BUENOS AIRES, 2014, 74 (06) : 457 - 461
  • [9] Differences in bone mineral metabolism normocalcemic primary hyperparathyroidism with respect to classical primary hyperparathyroidism
    Sosa C, Ramos
    Gomez, V
    Hernandez D, Hernandez
    Garcia A, Deniz
    de Tejada Romero, Gomez M. J.
    Henriquez M, Sosa
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2020, 12 (01) : 14 - 19
  • [10] Bone Mineral Density Evolution After Successful Parathyroidectomy in Patients With Normocalcemic Primary Hyperparathyroidism
    Koumakis, Eugenie
    Souberbielle, Jean-Claude
    Sarfati, Emile
    Meunier, Marine
    Maury, Emilie
    Gallimard, Elizabeth
    Borderie, Didier
    Kahan, Andre
    Cormier, Catherine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (08): : 3213 - 3220